STAT3 and prostate carcinoma: According to this evidence, the authors showed that PC3 cells (prostate cancer cell line bearing a STAT3 whole-gene-deletion mutation) had low mitochondrial membrane potential that increased significantly, together with ATP production, after Stat3 transfection.